At the request of the exchanges, the U.S./Hong Kong stock quotes are displayed on a 15-minute delay, download the APP to view the real-time quotes for free.
Close
DNA Ginkgo Bioworks Holdings Inc.
Not Yet Opened 12-10 16:00:00 EST
9.78
+0.22
+2.30%
盘后10.07
+0.29+2.99%
19:55 EST
High10.05Low9.34Vol1.10M
Open9.54D1 Closing9.56Amplitude7.43%
Mkt Cap592.57MTradable Cap406.23MTotal Shares60.59M
T/O10.79MT/O Rate2.66%Tradable Shares41.54M
P/B--ROE--EPS0.00
52wk High--52wk Low--P/E--
Dividend--Div.Yield--ROA--

Loading ...

Ginkgo Bioworks Partners With Deep Origin-Led Team on ARPA-H to Develop Drug Safety Platform
MT Newswires Live  ·  12-09 23:26
Ginkgo Bioworks Partners With Deep Origin-Led Team on ARPA-H to Develop Drug Safety Platform
BRIEF-Ginkgo Bioworks Holdings Inc - Selected By Pnnl To Deliver A Modular, High‑Throughput Phenotyping Platform For Doe's M2pc
Reuters  ·  12-05
BRIEF-Ginkgo Bioworks Holdings Inc - Selected By Pnnl To Deliver A Modular, High‑Throughput Phenotyping Platform For Doe's M2pc
Ginkgo Bioworks Holdings Inc - Awarded by Environmental Molecular Sciences Laboratory a Four-Year, up to $47M Contract
THOMSON REUTERS  ·  12-05
Ginkgo Bioworks Holdings Inc - Awarded by Environmental Molecular Sciences Laboratory a Four-Year, up to $47M Contract
Ginkgo Bioworks Holdings Inc - Selected by Pnnl to Deliver a Modular, High‑Throughput Phenotyping Platform for Doe's M2PC
THOMSON REUTERS  ·  12-05
Ginkgo Bioworks Holdings Inc - Selected by Pnnl to Deliver a Modular, High‑Throughput Phenotyping Platform for Doe's M2PC
Ginkgo Bioworks Wins Up to $47 Million Contract to Build Automated Phenotyping Platform for PNNL
Reuters  ·  12-05
Ginkgo Bioworks Wins Up to $47 Million Contract to Build Automated Phenotyping Platform for PNNL
Is Twist’s New Endotoxin‑Controlled Plasmid DNA Offering Altering The Investment Case For TWST?
Simply Wall St.  ·  12-05
Is Twist’s New Endotoxin‑Controlled Plasmid DNA Offering Altering The Investment Case For TWST?
Twist Bioscience Introduces New Plasmid DNA Preparation Products
MT Newswires Live  ·  12-04
Twist Bioscience Introduces New Plasmid DNA Preparation Products
Ginkgo Bioworks Joins STRM.BIO-Led Consortium to Advance In Vivo CAR-T Therapies
Reuters  ·  12-03
Ginkgo Bioworks Joins STRM.BIO-Led Consortium to Advance In Vivo CAR-T Therapies
Miss These Genesis Mission Stocks, and You’ll Regret It for a Decade
InvestorPlace  ·  12-02
Miss These Genesis Mission Stocks, and You’ll Regret It for a Decade
We Think OKP Holdings (SGX:5CF) Might Have The DNA Of A Multi-Bagger
Simply Wall St.  ·  11-29
We Think OKP Holdings (SGX:5CF) Might Have The DNA Of A Multi-Bagger
Ginkgo Bioworks Q3 Net Income USD -80.755 Million
Reuters  ·  11-20
Ginkgo Bioworks Q3 Net Income USD -80.755 Million
Ginkgo Bioworks Collaborating With Institute for Genomic Biology on Oral Health
MT Newswires Live  ·  11-18
Ginkgo Bioworks Collaborating With Institute for Genomic Biology on Oral Health
Applied DNA Sciences Rebrands to BNB Plus Corp.
TIPRANKS  ·  11-18
Applied DNA Sciences Rebrands to BNB Plus Corp.
Applied DNA chairperson Judy Murrah steps down, Josh Kruger to succeed
TIPRANKS  ·  11-17
Applied DNA chairperson Judy Murrah steps down, Josh Kruger to succeed
Institutional shareholders may be less affected by Ginkgo Bioworks Holdings, Inc.'s (NYSE:DNA) pullback last week after a year of 2.2% returns
Simply Wall St.  ·  11-10
Institutional shareholders may be less affected by Ginkgo Bioworks Holdings, Inc.'s (NYSE:DNA) pullback last week after a year of 2.2% returns
Couple Dubbed "Most Alike Online" Respond to DNA Test Requests, Wife Shares Their Journey
Deep News  ·  11-09
Couple Dubbed "Most Alike Online" Respond to DNA Test Requests, Wife Shares Their Journey
Bank of America Securities Remains a Sell on Ginkgo Bioworks Holdings (DNA)
TIPRANKS  ·  11-08
Bank of America Securities Remains a Sell on Ginkgo Bioworks Holdings (DNA)
James Watson, Who Codiscovered DNA Structure, Dies at 97 -- WSJ
Dow Jones  ·  11-08
James Watson, Who Codiscovered DNA Structure, Dies at 97 -- WSJ
U.S. RESEARCH ROUNDUP-Blackline, Carmax, Expedia
Reuters  ·  11-07
U.S. RESEARCH ROUNDUP-Blackline, Carmax, Expedia
Ginkgo Bioworks Holdings Inc : TD Cowen Cuts Target Price to $14 From $18
THOMSON REUTERS  ·  11-07
Ginkgo Bioworks Holdings Inc : TD Cowen Cuts Target Price to $14 From $18

Introduction

Company Name.
Ginkgo Bioworks Holdings Inc.
Affiliated Markets:
NYSE
Listing Date:
--
Main Business:
Ginkgo Bioworks Holdings, Inc., together with its subsidiaries, develops platform for cell programming. Its platform is used to program cells to enable biological production of products, such as novel therapeutics, food ingredients, and chemicals derived from petroleum. The company serves various end markets, including specialty chemicals, agriculture, food, consumer products, and pharmaceuticals. Ginkgo Bioworks Holdings, Inc. was founded in 2008 and is headquartered in Boston, Massachusetts.
Issue price:
--